The Research and Development team at XinThera Inc. is responsible for utilizing cutting-edge computational chemistry technologies to design innovative drugs targeting critical areas in oncology and immunology. They conduct detailed research on emerging and well-validated targets, develop lead compounds, oversee preclinical studies, and translate scientific discoveries into viable therapeutic candidates. The team works collaboratively across various disciplines including chemistry, biology, and pharmacokinetics to advance the pipeline of breakthrough medicines.
Craig Murphy
Vice President, Immunology
Joseph Pinchman
Director Of Chemistry
Kevin DeMent
Director, DMPK
Nathan Ihle
Senior Director of Oncology
Nisha Patel
Director, Translational Oncolo...
Porino Va
Director of Medicinal Chemistr...
Ray Fang
Sr. Director, Biology
Robert Hoffman
VP Chemistry
Xuemei (Sherry) Zhao
Sr. Scientist
View all